Corporate Profile

Strongbridge Biopharma is a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs. Founded in 1996, the Company is publicly traded on the NASDAQ Global Market under the ticker symbol SBBP.

Read More

 | (Common Stock)
Stock chart for: SBBP.O.  Currently trading at $4.40 with a 52 week high of $6.24 and a 52 week low of $2.00.
Data Provided by Refinitiv. Minimum 15 minutes delayed.